Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Vary drug prices for different conditions, say health experts
The NHS could improve patients’ access to new cancer treatments by paying different prices for drugs depending on the disease they are used to treat, concludes a group of experts from across academia and industry.
Prostate cancer drug targeting Achilles heel approved in Europe
The Institute of Cancer Research, London, has strongly welcomed the approval by the European Commission of the targeted drug olaparib for men with advanced prostate cancers with genetic alterations in BRCA1 or BRCA2.
NCRI 2020: New bowel cancer model uncovering how it avoids immunotherapy drug
Scientists at The Institute of Cancer Research, London, have developed a complex model system that mimics the most common form of bowel cancer and is showing how it ‘hides’ from immunotherapy.
Low-cost test could pick out breast cancer patients at increased risk of relapse
Testing women’s response to hormone therapy for breast cancer given around the time of surgery could be a fast and cheap way of predicting how likely the disease is to come back, a major clinical trial has found.
ICR welcomes NICE’s decision to reassess abiraterone as first-line treatment for advanced prostate cancer
The Institute of Cancer Research, London, has welcomed the announcement by NICE that it will reconsider its decision not to recommend abiraterone as a first-line treatment for newly diagnosed, advanced prostate cancer.
New drug for difficult-to-drug cancer mutation could be key treatment for a range of cancers
A new drug designed to counter the effects of an important, but very hard to target, cancer mutation could be effective against a range of tumour types including lung and gynaecological cancers, a new clinical trial shows.
ICR calls for change to bring immunotherapies to more cancer patients
Major changes to the way immunotherapy drugs are researched and evaluated are essential if they are to become successful treatment options for many more types of cancers, leading cancer experts are warning.
ICR is top-ranked university for invention income for seventh consecutive year
The Institute of Cancer Research, London, has again been the most successful academic institution in the UK at making income from its intellectual property – for the seventh successive year.
ICR Discovery Club gives members a virtual glimpse into the cancer genetics lab
Members of the ICR’s Discovery Club were given an exclusive insight into how researchers sample, process and analyse tumour cells in the lab, as part of the ICR’s first virtual event for our donors.
Study seeks to find out why black men develop prostate cancer at twice the rate of other men
A first-of-its-kind study in the UK is aiming to solve the mystery of why black men develop prostate cancer at twice the rate of other men in the UK.
New study sheds light on the best drug choices for some patients with advanced breast cancer
Patients with metastatic breast cancer carrying a particular mutation fare better on one form of hormone therapy than another and can be identified using a blood test, according to a new study.
-547x410.png?sfvrsn=6c38d100_2 "cell-division-(green-4-3) 547x410")
Scientists reveal important role for ‘workhorse’ of cell division
A new study shows how a crucial protein, which acts as trigger for cell division, helps release another key protein from the cell’s ‘control centre’.